WASHINGTON (MedPage Today) -- The investigational antibiotic iclaprim is as effective as linezolid (Zyvox) in treating skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA), a researcher said here.
ICAAC-IDSA: Investigational Antibiotic as Effective as Linezolid...Courtesy MedPage Today Infectious Disease Tue, 10/28/2008 - 12:58
WASHINGTON (MedPage Today) -- The investigational antibiotic iclaprim is as effective as linezolid (Zyvox) in treating skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA), a researcher said here. Tags:
More related itemsPets Risk Factor for MRSA (CME/CE)
DDW: Hospitalized IBD Patients More Susceptible to...
Flu-like Illness May Herald CA-MRSA Pneumonia (CME/CE)
|
Popular by tags WeekMonth |
Post new comment